BACKGROUND: Mycosis Fungoides (MF) is the most common cutaneous T cell lymphoma, accounting for 54-72 % of cases. When it presents as solitary or oligolesional picture, radiotherapy is considered potentially curative. To verify this we decided to evaluate the outcome in 15 patients studied in the period 1990-2007 after ten years. METHODS: The files of the patients were revised and they were recalled for a control. Two new cases were added. On the whole 17 patients were studied. All patients underwent histopathological ascertainment and staging investigations. All lesions were treated with conventional radiation therapy with a median dose of 25 Gy. RESULTS: After 1 month from the end of radiotherapy, complete remission (CR) occurred in 22 treatment fields (95, 6%) and partial remission(PR) in one (4,4%). Radiotherapy was always well tolerated. At the last recorded visit (median follow up 130 months) 15 patients were alive without disease, and two had localized evidence of MF lesions, with a total 5-year cure-rate of 63.24% and of 66.71% if referred to the original updated series. None of the patients showed progression of the disease. CONCLUSIONS: Our results confirm that radiation therapy in the treatment of minimal stage MF contributes to afford good and durable results with negligible side effects and maintenance of good quality of life over the time.

Results of radiotherapy in minimal stage mycosis fungoides : a reappraisal after ten years / L. Esposito, R. Piccinno, L. Marchese, E. Berti. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 1827-1820. - (2018 Feb 26). [Epub ahead of print] [10.23736/S0392-0488.18.05914-X]

Results of radiotherapy in minimal stage mycosis fungoides : a reappraisal after ten years

L. Esposito;L. Marchese;E. Berti
2018

Abstract

BACKGROUND: Mycosis Fungoides (MF) is the most common cutaneous T cell lymphoma, accounting for 54-72 % of cases. When it presents as solitary or oligolesional picture, radiotherapy is considered potentially curative. To verify this we decided to evaluate the outcome in 15 patients studied in the period 1990-2007 after ten years. METHODS: The files of the patients were revised and they were recalled for a control. Two new cases were added. On the whole 17 patients were studied. All patients underwent histopathological ascertainment and staging investigations. All lesions were treated with conventional radiation therapy with a median dose of 25 Gy. RESULTS: After 1 month from the end of radiotherapy, complete remission (CR) occurred in 22 treatment fields (95, 6%) and partial remission(PR) in one (4,4%). Radiotherapy was always well tolerated. At the last recorded visit (median follow up 130 months) 15 patients were alive without disease, and two had localized evidence of MF lesions, with a total 5-year cure-rate of 63.24% and of 66.71% if referred to the original updated series. None of the patients showed progression of the disease. CONCLUSIONS: Our results confirm that radiation therapy in the treatment of minimal stage MF contributes to afford good and durable results with negligible side effects and maintenance of good quality of life over the time.
No
English
Mycosis fungoides; Oligolesional mycosis fungoides; Radiotherapy; Unilesional mycosis fungoide
Settore MED/35 - Malattie Cutanee e Veneree
Articolo
Esperti anonimi
Pubblicazione scientifica
26-feb-2018
26-feb-2018
Minerva medica
Epub ahead of print
Periodico con rilevanza internazionale
pubmed
Aderisco
info:eu-repo/semantics/article
Results of radiotherapy in minimal stage mycosis fungoides : a reappraisal after ten years / L. Esposito, R. Piccinno, L. Marchese, E. Berti. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 1827-1820. - (2018 Feb 26). [Epub ahead of print] [10.23736/S0392-0488.18.05914-X]
reserved
Prodotti della ricerca::01 - Articolo su periodico
4
262
Article (author)
Periodico con Impact Factor
L. Esposito, R. Piccinno, L. Marchese, E. Berti
File in questo prodotto:
File Dimensione Formato  
Results of radiotherapy Esposito-Piccinno-Marchese-Berti (G Ital Dermatol Venereol in press 2019).pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 171.91 kB
Formato Adobe PDF
171.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/559416
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact